SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

April 7, 2004

(Date of earliest event reported)

PHARMACYCLICS, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-26658	94-3148201
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

995 E. Arques Avenue
Sunnyvale, California 94085-4521
(408) 774-0330

(Address of principal executive offices including zip code and registrant’s telephone number, including
area code)

TABLE OF CONTENTS

	Item 5. Other Events
	Item 7. Financial Statements and Exhibits.
SIGNATURE
INDEX TO EXHIBITS
EXHIBIT 99.1

Item 5. Other Events

     On April 7, 2004, Pharmacyclics, Inc. (the “Registrant”) issued a press release announcing the closing of its previously announced underwritten public offering of 3,200,000 shares of common stock, which includes shares issued pursuant to the exercise of the underwriter’s over-allotment option. The Registrant’s press release announcing the closing of the public offering is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 7. Financial Statements and Exhibits.

                    (c) Exhibits.

Exhibit No.	Description
99.1	Press release of Registrant, dated April 7, 2004.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 7, 2004
	PHARMACYCLICS, INC.
	By: Name: Title:	/s/ LEIV LEA Leiv Lea Vice President, Finance & Administration and CFO and Secretary

INDEX TO EXHIBITS FILED WITH
THE CURRENT REPORT ON FORM 8-K DATED APRIL 8, 2004

Exhibit	Description
99.1	Press release of Registrant, dated April 7, 2004.